Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Th17 cells are a distinct lineage of effector CD4+ T cells characterized by their production of interleukin (IL)-17. We demonstrate that Th17 cells also expressed IL-22, an IL-10 family member, at substantially higher amounts than T helper (Th)1 or Th2 cells. Similar to IL-17A, IL-22 expression was initiated by transforming growth factor β signaling in the context of IL-6 and other proinflammatory cytokines. The subsequent expansion of IL-22–producing cells was dependent on IL-23. We further demonstrate that IL-22 was coexpressed in vitro and in vivo with both IL-17A and IL-17F. To study a functional relationship among these cytokines, we examined the expression of antimicrobial peptides by primary keratinocytes treated with combinations of IL-22, IL-17A, and IL-17F. IL-22 in conjunction with IL-17A or IL-17F synergistically induced the expression of β-defensin 2 and S100A9 and additively enhanced the expression of S100A7 and S100A8. Collectively, we have identified IL-22 as a new cytokine expressed by Th17 cells that synergizes with IL-17A or IL-17F to regulate genes associated with skin innate immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which are induced by IL-17 during infection (see section below) [28,31].”
From Host–Candida auris interactions in the skin (2026) · cites this paper as [31]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“S100A7 and S100A8 are strongly regulated by IL-17 and IL-22 in keratinocytes.25,39”
From The Innate Immune System in Acute and Chronic Wounds (2016) · cites this paper as [39]
The cited source says what the claim attributes to it.
In the citing paper
“IL-17A and IL-22 are two members of the cytokine family with substantial roles in host defense and other immunoregulatory functions.25,36,39,69–72”
From The Innate Immune System in Acute and Chronic Wounds (2016) · cites this paper as [39]
In the citing paper
“IL-22, another product of Th17 cells, appears to be protective in the bleomycin model (150)”
From The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis (2018) · cites this paper as [150]
In the citing paper
“IL-1, TNFα, IFNγ, IL-17, and IL-22 are strong inducers of hBD2 and hBD3 expression.25,36,39”
From The Innate Immune System in Acute and Chronic Wounds (2016) · cites this paper as [39]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087 · cited 1×
“Also, IL-23p19–defi cient mice are very susceptible to Citrobacter rodentium infection despite maintaining wild-type expression of IL-17A (7).”
BackgroundInterleukin-17 Family Members and Inflammation
Kolls, J. K., & Lindén, A. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.018 · Cited by 2,372 · cited 2×
“Similar to IL-17A and IL-17F, IL-22 induces IL-6, CXCL8, and MCP-1 expression by fi broblast cells (1, 13, 14).”
BackgroundAggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847
Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation
Murphy, C. A., Langrish, C. L., Chen, Y., Blumenschein, W., McClanahan, T., Kastelein, R. A., Sedgwick, J. D., & Cua, D. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030896 · Cited by 1,669 · cited 1×
“For example, IL-23p19–defi cient mice are completely resistant to disease in collagen-induced arthritis, whereas IL-17A– defi cient mice remain susceptible, albeit with a signifi cantly reduced incidence and severity (9, 10).”
BackgroundIL-22 Increases the Innate Immunity of Tissues
Wolk, K., Kunz, S., Witte, E., Friedrich, M., Asadullah, K., & Sabat, R. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.007 · Cited by 1,359 · cited 7×
“Keratinocytes treated with a combination of IL-17A and IL-17F enhanced S100A8, but did not further enhance expression of hBD-2, S100A7, or S100A9.”
BackgroundInfluential
Cited by
Items 401–500 of 1,006
Petrolatum: Barrier repair and antimicrobial responses underlying this “inert” moisturizer
Czarnowicki, T., Malajian, D., Khattri, S., Correa da Rosa, J., Dutt, R., Finney, R., Dhingra, N., Xiangyu, P., Xu, H., Estrada, Y. D., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.08.013 · Cited by 161
Martin, J. C., Bériou, G., Heslan, M., Chauvin, C., Utriainen, L., Aumeunier, A., Scott, C. L., Mowat, A., Cerovic, V, Houston, S. A., et al. (2014) · Mucosal Immunology · doi:10.1038/mi.2013.28 · Cited by 149
“These paradoxical effects of IL-22 are dependent on the context of IL-22 production,(13) as IL-22 can synergistically act with other inflammatory cytokines, including IL-17 and tumor necrosis factor-a.(13,14) A tight regulation of the IL-22/IL-22R axis appears therefore critical in maintaining the beneficial effects o…”
BackgroundNyirenda, M. H., Sanvito, L., Darlington, P. J., O’Brien, K., Zhang, G.-X., Constantinescu, C. S., Bar-Or, A., & Gran, B. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003715 · Cited by 160
“IL-22, an IL-10 family member, is highly expressed by Th17 cells, and its expression can be induced by TGF-b signaling in the presence of IL6 and other proinflammatory cytokines (38).”
BackgroundIL-17 in the immunopathogenesis of spondyloarthritis
Taams, L. S., Steel, K. J. A., Srenathan, U., Burns, L. A., & Kirkham, B. W. (2018) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0044-2 · Cited by 158
Psoriasis: Classical vs. Paradoxical. The Yin-Yang of TNF and Type I Interferon
Mylonas, A., & Conrad, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02746 · Cited by 172
“IL-22, which is produced by TH17 cells (71) and exclusively by a distinct TH22 subpopulation (72, 73), had previously been regarded as a very promising target.”
BackgroundIL-17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa
Fletcher, J. M., Moran, B., Petrasca, A., & Smith, C. M. (2020) · Clinical and Experimental Immunology · doi:10.1111/cei.13449 · Cited by 154
Hönzke, S., Wallmeyer, L., Ostrowski, A., Radbruch, M., Mundhenk, L., Schäfer‐Korting, M., & Hedtrich, S. (2015) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2015.11.007 · Cited by 177
“Interestingly, other T cell-derived cytokines, such as IL-17 and IL-22, have been found to synergistically increase hBD-2 expression and thus also seem to play an important role in the regulation of skin innate immunity (Liang et al., 2006).”
BackgroundIL-21 induces IL-22 production in CD4+ T cells
Yeste, A., Mascanfroni, I. D., Nadeau, M., Burns, E. J., Tukpah, A.-M., Santiago, A., Wu, C., Patel, B., Kumar, D., & Quintana, F. J. (2014) · Nature Communications · doi:10.1038/ncomms4753 · Cited by 159
The presence, function and regulation of IL‐17 and Th17 cells in periodontitis
Cheng, W., Hughes, F. J., & Taams, L. S. (2014) · Journal of Clinical Periodontology · doi:10.1111/jcpe.12238 · Cited by 159
Desel, C., Dorhoi, A., Bandermann, S., Grode, L., Eisele, B., & Kaufmann, S. H. E. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir592 · Cited by 159
“IL-22–producing cells have been identified in patients with TB, but these cells seem to be distinct from IL-17–producing cells [18].”
BackgroundInfluentialThe role of inflammasome-derived IL-1 in driving IL-17 responses
Mills, K. H. G., Dungan, L. S., Jones, S. A., & Harris, J. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1012543 · Cited by 153
“tant in tight junction stability [117–129].”
Cationic antimicrobial peptides in psoriatic skin cooperate to break innate tolerance to self‐DNA
Lande, R., Chamilos, G., Ganguly, D., Demaria, O., Frasca, L., Durr, S., Conrad, C., Schröder, J., & Gilliet, M. F. (2014) · European Journal of Immunology · doi:10.1002/eji.201344277 · Cited by 178
Armstrong, A. W., Voyles, S. V., Armstrong, E. J., Fuller, E. N., & Rutledge, J. C. (2011) · Experimental Dermatology · doi:10.1111/j.1600-0625.2011.01308.x · Cited by 152
Phenotype Switching by Inflammation-Inducing Polarized Th17 Cells, but Not by Th1 Cells
Shi, G., Cox, C. A., Vistica, B. P., Tan, C., Wawrousek, E. F., & Gery, I. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.7205 · Cited by 156
“Published information concerning culture conditions that induce naive CD4 cells to acquire a Th17 phenotype (9, 20) allowed us to generate polarized HELspecific Th17 lines and to compare them with Th1 lines.”
ResultCritical role of Th17 responses in a murine model of Neisseria gonorrhoeae genital infection
Feinen, B., Jerse, A. E., Gaffen, S. L., & Russell, M. W. (2010) · Mucosal Immunology · doi:10.1038/mi.2009.139 · Cited by 158
Inflammasome-IL-1-Th17 response in allergic lung inflammation
Besnard, A., Togbe, D., Couillin, I., Tan, Z., Zheng, S. G., Erard, F., Bert, M. L., Quesniaux, V. F. J., & Ryffel, B. (2011) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjr042 · Cited by 164
“Emerging data suggest that IL-22 may provide mucosal protection by accelerating epithelial repair, as well as maintaining epithelial integrity (Liang et al., 2006; Zheng et al., 2007; Aujla et al., 2008).”
BackgroundLacey, K., Geoghegan, J., & McLoughlin, R. (2016) · Pathogens · doi:10.3390/pathogens5010022 · Cited by 146
“In addition, IL-17 can also induce keratinocytes to produce antimicrobial peptides [36].”
BackgroundTGF-β signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancer
Pérez, L. G., Kempski, J., McGee, H. M., Pelczar, P., Agalioti, T., Giannou, A. D., Konczalla, L., Brockmann, L., Wahib, R., Xu, H. Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16363-w · Cited by 178
The involvement of TH17 cells in the pathogenesis of IBD
Jiang, P., Zheng, C., Xiang, Y., Malik, S., Su, D., Xu, G., & Zhang, M. (2022) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2022.07.005 · Cited by 158
Control of adaptive immunity by pattern recognition receptors
Carroll, S. L., Pasare, C., & Barton, G. M. (2024) · Immunity · doi:10.1016/j.immuni.2024.03.014 · Cited by 170
Grasberger, H., Gao, J., Nagao‐Kitamoto, H., Kitamoto, S., Zhang, M., Kamada, N., Eaton, K. A., Zaatari, M. E., Shreiner, A. B., Merchant, J. L., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.062 · Cited by 168
Therapeutic antibodies that target inflammatory cytokines in autoimmune diseases
Lai, Y., & Dong, C. (2015) · International Immunology · doi:10.1093/intimm/dxv063 · Cited by 162
Kotobuki, Y., Tanemura, A., Yang, L., Itoi, S., Wataya‐Kaneda, M., Murota, H., Fujimoto, M., Serada, S., Naka, T., & Katayama, I. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00945.x · Cited by 158
“IL-17A stimulates the production of IL-1b, TNF-a, and IL-6 (Kolls and Linden, 2004; Liang et al., 2006).”
BackgroundGodinez, I., Haneda, T., Raffatellu, M., George, M. D., Paixão, T. A., Rolán, H. G., Santos, R. L., Dandekar, S., Tsolis, R. M., & Bäumler, A. J. (2008) · Infection and Immunity · doi:10.1128/iai.01691-07 · Cited by 151
“Consistent with this idea, we found that mRNA levels upregulated most dramatically during serotype Typhimurium infection of the cecal mucosa included genes encoding T-cell-derived cytokines (i.e., IL-22, IL-17, and IFN- ) and genes whose expression is known to be regulated by these cytokines.”
BackgroundInfluentialDendritic epidermal T cells regulate skin antimicrobial barrier function
MacLeod, A. S., Hemmers, S., Garijo, O., Chabod, M., Mowen, K., Witherden, D. A., & Havran, W. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70064 · Cited by 152
“Furthermore, in contrast with findings in other IL-17A– producing T cells (44, 50) and despite upregulation of ROR γ t in DETC upon activation, only a subset of TCR-stimulated ROR γ t + DETC was able to produce large amounts of IL-17A, suggesting that induction of ROR γ t alone is not sufficient to…”
The role of Th17 lymphocytes in the autoimmune and chronic inflammatory diseases
Murdaca, G., Colombo, B. M., & Puppo, F. (2011) · Internal and Emergency Medicine · doi:10.1007/s11739-011-0517-7 · Cited by 158
“human beta defensin-2) in bronchial epithelial cells [ 15 ].”
BackgroundSkin Immunity to Candida albicans
Kashem, S. W., & Kaplan, D. H. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.04.007 · Cited by 147
“In non-hematopoietic cells such as KCs, IL-17 induces the transcription of proinflammatory cytokines such as IL-6, G-CSF, chemokines such as CCL20, and the antimicrobial peptides b-defensins and S100A proteins [44,78].”
BackgroundBrockmann, L., Giannou, A., Gagliani, N., & Huber, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18051033 · Cited by 144
Psoriasis: rationale for targeting interleukin-17
Girolomoni, G., Mrowietz, U., & Paul, C. F. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11099.x · Cited by 172
Innate Lymphoid Cells: Balancing Immunity, Inflammation, and Tissue Repair in the Intestine
Tait Wojno, E. D., & Artis, D. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.10.003 · Cited by 137
“, 2011b), including production of antimicrobial peptides (Liang et al., 2006).”
BackgroundOrganization of the skin immune system and compartmentalized immune responses in infectious diseases
Quaresma, J. A. S. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00034-18 · Cited by 149
Chege, D., Sheth, P. M., Kain, T., Kim, C. J., Kovacs, C. M., Loutfy, M. R., Halpenny, R., Kandel, G. P., Chun, T., Ostrowski, M., et al. (2011) · AIDS · doi:10.1097/qad.0b013e328344cefb · Cited by 164
Mucocutaneous IL-17 immunity in mice and humans: host defense vs. excessive inflammation
Li, J., Casanova, J.-L., & Puel, A. (2018) · Mucosal Immunology · doi:10.1038/mi.2017.97 · Cited by 146
Interleukin‐17: A New Paradigm in Inflammation, Autoimmunity, and Therapy
Kramer, J. M., & Gaffen, S. L. (2007) · Journal of Periodontology · doi:10.1902/jop.2007.060392 · Cited by 147
Inducible Innate Resistance of Lung Epithelium to Infection
Evans, S. E., Xu, Y., Tuvim, M. J., & Dickey, B. F. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135909 · Cited by 167
“IL-17 plays important roles in mucosal defense against extracellular lung pathogens (108, 109) and upregulates the production of antimicrobial proteins by lung epithelial cells (107, 110).”
BackgroundMurakami, M., Hagforsen, E., Morhenn, V. B., Ishida‐Yamamoto, A., & Iizuka, H. (2011) · Experimental Dermatology · doi:10.1111/j.1600-0625.2011.01325.x · Cited by 147
The IL‐17 pathway as a major therapeutic target in autoimmune diseases
Hu, Y., Shen, F., Crellin, N. K., & Ouyang, W. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05825.x · Cited by 156
Rácz, E., Prens, E. P., Kurek, D., Kant, M., de Ridder, D., Mourits, S., Baerveldt, E. M., Özgür, Z., van IJcken, W. F. J., Laman, J. D., et al. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.53 · Cited by 156
“In addition, the IL-22-induced expression of human b-defensin-2 in the epidermis (Liang et al., 2006; Sa et al., 2007) was also drastically inhibited by NB-UVB (Figure 2f).”
BackgroundNLRC4 expression in intestinal epithelial cells mediates protection against an enteric pathogen
Nordlander, S., Pott, J., & Maloy, K. J. (2014) · Mucosal Immunology · doi:10.1038/mi.2013.95 · Cited by 145
“39 We found significantly increased IL-17A levels in cecal explants from infected Nlrc4 −/− mice, concomitant with highly elevated expression of s100A8 and s100A9, confirming that IL-17A mediated responses were not reduced, but in fact exaggerated, in susceptible animals.”
Hyper IgE syndromes: clinical and molecular characteristics
Al‐Shaikhly, T., & Ochs, H. D. (2018) · Immunology and Cell Biology · doi:10.1111/imcb.12209 · Cited by 154
Inflammatory bowel disease, past, present and future: lessons from animal models
Mizoguchi, A., & Mizoguchi, E. (2008) · Journal of Gastroenterology · doi:10.1007/s00535-007-2111-3 · Cited by 168
Human colostrum oligosaccharides modulate major immunologic pathways of immature human intestine
He, Y., Liu, S., Leone, S., & Newburg, D. S. (2014) · Mucosal Immunology · doi:10.1038/mi.2014.20 · Cited by 157
Biological and pathological activities of interleukin-22
Perusina Lanfranca, M., Lin, Y., Fang, J., Zou, W., & Frankel, T. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1391-6 · Cited by 141
Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes
Lee, S.-M., Yang, H., Tartar, D. M., Gao, B., Luo, X., Ye, S. Q., Zaghouani, H., & Fang, D. (2011) · Diabetologia · doi:10.1007/s00125-011-2064-1 · Cited by 142
“Since IFN-γ has suppressive functions in T helper (Th)17 polarisation [23, 24], the increase in IL-17-producing T cells may have been partially due to the decreased number of IFN-γ in spleen and pancreatic lymph nodes from resveratrol-treated mice.”
BackgroundTh17 cells and IL-17 A—Focus on immunopathogenesis and immunotherapeutics
van den Berg, W. B., & McInnes, I. B. (2013) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2013.04.006 · Cited by 155
“Additional actions of IL-17A on keratinocytes include upregulation of β-defensins and S100A family members, which provides a potential stimulus for the innate immune system [47,49]; downregulation of filaggrin and other factors involved in cell adhesion, which may contribute to skin barrier disruption [50]; and increa…”
BackgroundRabeony, H., Petit-Paris, I., Garnier, J., Barrault, C., Pedretti, N., Guilloteau, K., Jegou, J.-F., Guillet, G., Huguier, V., Lecron, J.-C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101937 · Cited by 140
“Cytokine combinations such as IL-17A and IFNc, IL-17A and TNFa or IL-17A and IL-22 result in a synergistic effect on chemokine and antimicrobial peptide production [7–9].”
Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus
Martin, J. C., Baeten, D., & Josien, R. (2014) · Clinical Immunology · doi:10.1016/j.clim.2014.05.004 · Cited by 149
Th17 cytokines and vaccine-induced immunity
Lin, Y., Slight-Webb, S. R., & Khader, S. A. (2010) · Seminars in Immunopathology · doi:10.1007/s00281-009-0191-2 · Cited by 156
“Moreover, production of IL-17 and IL-22 in human subjects showed a strong and independent association with protection against Kala alzhar, the disease caused by L. donovani [84].”
InfluentialT cell–derived inducible nitric oxide synthase switches off TH17 cell differentiation
Yang, J., Zhang, R., Lu, G., Shen, Y., Peng, L., Zhu, C., Cui, M., Wang, W., Arnaboldi, P., Tang, M., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20122494 · Cited by 137
“TH17 cells mediate proinflammatory and autoimmune responses through the production of TH17 signature cytokines including IL-17A, IL-17F, and IL-22 (Liang et al., 2006; Weaver et al., 2006; Bettelli et al., 2007; Zheng et al., 2007).”
Sirtuin-1 Activation Controls Tumor Growth by Impeding Th17 Differentiation via STAT3 Deacetylation
Limagne, E., Thibaudin, M., Euvrard, R., Berger, H., Chalons, P., Végan, F., Humblin, E., Boidot, R., Rébé, C., Derangère, V., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.004 · Cited by 138
“Th17 cells are characterized by their capacity to secrete IL-17A, IL-17F, IL-21, IL-22, and CCL20 (Dong, 2008; Liang et al., 2006).”
BackgroundAgak, G. W., Kao, S., Ouyang, K., Qin, M., Moon, D., Butt, A., & Kim, J. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.07.842 · Cited by 139
“In addition, both IL-17 and IL-22 induce antimicrobial peptide production from epithelial cells in humans (Liang et al., 2006; Ouyang et al., 2008; Wilson et al., 2007).”
Regulation of a Late Phase of T Cell Polarity and Effector Functions by Crtam
Yeh, J.-H., Sidhu, S. S., & Chan, A. C. (2008) · Cell · doi:10.1016/j.cell.2008.01.013 · Cited by 149
“A more modest reduction in IL22, but not IL17, was observed when cells were incubated with IL23, a condition that preferentially induces IL22 during primary T cell activation (Liang et al., 2006; Zheng et al., 2007) (Figure S6).”
AP-1 Activated by Toll-like Receptors Regulates Expression of IL-23 p19
Liu, W., Ouyang, X., Yang, J., Liu, J., Li, Q., Gu, Y., Fukata, M., Lin, T. R., He, C., Abreu, M. T., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.025528 · Cited by 149
Simon, D., Radonjic-Hösli, S., Straumann, A., Yousefi, S., & Simon, H.-U. (2015) · Allergy · doi:10.1111/all.12570 · Cited by 138
“In agreement with a previous study, we found only minimal expression of IL-17, a cytokine that is known to stimulate antimicrobial peptide expression by epithelial cells (50, 51).”
ResultShin, J. H., Shin, D. W., & Noh, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.03.008 · Cited by 144
Bernard, F., Morel, F., Camus, M., Pedretti, N., Barrault, C., Garnier, J., & Lecron, J. (2012) · Journal of Allergy · doi:10.1155/2012/718725 · Cited by 157
“IL-17A and IL-22 synergize in the upregulation of BD-2 and S100A9 production [22, 23].”
BackgroundZrioual, S., Toh, M.-L., Tournadre, A., Zhou, Y., Cazalis, M.-A., Pachot, A., Miossec, V., & Miossec, P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.1.655 · Cited by 137
Eyerich, S., Wagener, J., Wenzel, V., Scarponi, C., Pennino, D., Albanesi, C., Schaller, M., Behrendt, H., Ring, J., Schmidt‐Weber, C. B., et al. (2011) · European Journal of Immunology · doi:10.1002/eji.201041197 · Cited by 137
Chan, T. C.-C., Hawkes, J. E., & Krueger, J. G. (2018) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622318759282 · Cited by 138
A Double Edged Sword Role of Interleukin-22 in Wound Healing and Tissue Regeneration
Arshad, T., Mansur, F., Pálek, R., Manzoor, S., & Liška, V. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02148 · Cited by 150
“Commonly IL-22 elevates antimicrobial defense by up-regulating expression of certain antibacterial genes like psoriasin (S100A7), calgranulin-A (S100A8), calgranulin-B (S100A9), and Betadefensin 2 (BD-2) independently or in combination with IL-17A of IL-17F as per studied in primary human keratinocytes as well as in p…”
BackgroundEhteshamfar, S. M., Akhbari, M., Afshari, J. T., Seyedi, M., Nikfar, B., Moghaddam, A. S., Ghanbarzadeh, E., & Momtazi‐Borojeni, A. A. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16049 · Cited by 142
Interleukin-17-producing T helper cells in autoimmunity
Hemdan, N. Y. A., Birkenmeier, G., Wichmann, G., El-Saad, A. M. A., Krieger, T., Conrad, K., & Sack, U. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.07.003 · Cited by 154
HVEM signalling at mucosal barriers provides host defence against pathogenic bacteria
Shui, J.-W., Larange, A., Kim, G., Vela, J. L., Zahner, S., Cheroutre, H., & Kronenberg, M. (2012) · Nature · doi:10.1038/nature11242 · Cited by 132
Interleukin-26: An IL-10-related cytokine produced by Th17 cells
Donnelly, R. P., Sheikh, F. G., Dickensheets, H. L., Savan, R., Young, H. A., & Walter, M. R. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.09.001 · Cited by 141
Healing of intestinal inflammation by IL-22
Mizoguchi, A. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22929 · Cited by 153
“also synergistically promotes the expression of b-defensin 2 and S100A9 in keratinocytes.(53)”
BackgroundZhuang, Y., Peng, L., Zhao, Y., Shi, Y., Mao, X., Guo, G., Chen, W., Liu, X., Zhang, J., Liu, T., et al. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1241-5 · Cited by 144
Th17 cells, HIV and the gut mucosal barrier
Dandekar, S., George, M. D., & Bäumler, A. J. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e328335eda3 · Cited by 127
IL-29 Is Produced by T H 17 Cells and Mediates the Cutaneous Antiviral Competence in Psoriasis
Wolk, K., Witte, K., Witte, E., Raftery, M., Kokolakis, G., Philipp, S., Schönrich, G., Warszawska, K., Kirsch, S., Prösch, S., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006245 · Cited by 131
“The mechanisms underlying the relative ABP deficiency in AD lesions include (i) the lack of interleukin-17 (IL-17) (21), which is a strong ABP inducer and important amplifier of the action of other ABP inducers (18, 22); (ii) the presence of ABP–down-regulating TH2 effector cytokines such as IL-4 and IL-13 (20); and (…”
BackgroundMajor Role of the IL17/23 Axis in Psoriasis Supports the Development of New Targeted Therapies
Bugaut, H., & Aractingi, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.621956 · Cited by 151
Kim, S. W., Kim, E. S., Moon, C. M., Park, J. J., Kim, T. I., Kim, W. H., & Cheon, J. H. (2011) · Gut · doi:10.1136/gut.2011.238477 · Cited by 143
“RORC was recently identified as a master regulator of Th17 cytokine production.36However, transcription factors such as STAT3, RORa and IRF4 promote Th17 cytokine production,37e39 46 while Foxp3, Ets1, Gfi1, T-bet and Smad3 negatively regulate Th17.”
BackgroundBrenu, E. W., van Driel, M. L., Staines, D. R., Ashton, K. J., Hardcastle, S. L., Keane, J., Tajouri, L., Peterson, D., Ramos, S. B., & Marshall-Gradisnik, S. M. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-88 · Cited by 135
“IL-17A is expressed by Th17 cells, it recruits and activates neutrophils, stimulates the generation of pro-inflammatory cytokines, chemokines and increases antimicrobial gene expression [47-50].”
BackgroundKinoshita, H., Takai, T., Lê, T. A., Kamijo, S., Wang, X. L., Ushio, H., Hara, M., Kawasaki, J., Vu, A. T., Ogawa, T., et al. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.10.008 · Cited by 140
Putting together the psoriasis puzzle: an update on developing targeted therapies
Johnson-Huang, L. M., Lowes, M. A., & Krueger, J. G. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.009092 · Cited by 148
Cytokines and effector T cell subsets causing autoimmune CNS disease
Petermann, F., & Korn, T. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.064 · Cited by 128
“ut not on lymphoid cells [108,118,120,204–209]”
Stallhofer, J., Friedrich, M., Konrad-Zerna, A., Wetzke, M., Lohse, P., Glas, J., Tillack-Schreiber, C., Schnitzler, F., Beigel, F., & Brand, S. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000515 · Cited by 130
“IL-17A itself, along with IL-22, is known to promote the expression of antimicrobial peptides, such as S100 proteins, in epithelial cells as integral part of the mucosal host defense.(6,7) The heteromeric protein complex formed by S100A8 and S100A9, termed calprotectin, has evolved as a suitable biomarker for monitori…”
BackgroundChoreographing Immunity in the Skin Epithelial Barrier
Kobayashi, T., Naik, S., & Nagao, K. (2019) · Immunity · doi:10.1016/j.immuni.2019.02.023 · Cited by 129
Cytokine regulation of immunopathology in toxoplasmosis
Gaddi, P. J., & Yap, G. S. (2007) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100038 · Cited by 134
Regulation of IL-17 in Human CCR6+ Effector Memory T Cells
Liu, H., & Rohowsky-Kochan, C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.12.7948 · Cited by 131
“In mice, Th17 cells have been reported to secrete IL-17, TNF- , IL-22, and IL-6 (1, 20).”
BackgroundRole of STAT3 in inflammatory bowel disease
Sugimoto, K. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.5110 · Cited by 131
New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndrome
Conti, H. R., Baker, O., Freeman, A. F., Jang, W. S., Holland, S. M., Li, R. A., Edgerton, M., & Gaffen, S. L. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.5 · Cited by 133
Robinson, K. M., McHugh, K. J., Mandalapu, S., Clay, M. E., Lee, B., Scheller, E. V., Enelow, R. I., Chan, Y. R., Kolls, J. K., & Alcorn, J. F. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit527 · Cited by 131
IL-22 Fate Reporter Reveals Origin and Control of IL-22 Production in Homeostasis and Infection
Ahlfors, H., Morrison, P. J., Duarte, J. H., Li, Y., Biro, J., Tolaini, M., Di Meglio, P., Potocnik, A. J., & Stockinger, B. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401244 · Cited by 133
“IL-22 was previously identified as a Th17 cytokine (4).”
BackgroundGessner, M. A., Werner, J. L., Lilly, L. M., Nelson, M. P., Metz, A. E., Dunaway, C. W., Chan, Y. R., Ouyang, W., Brown, G. D., Weaver, C. T., et al. (2012) · Infection and Immunity · doi:10.1128/iai.05939-11 · Cited by 130
“With the explosion of IL-17A-related research over the last 5 years, studies have discovered that CD4 T cells producing IL-17A can also produce the cytokine IL-22, a member of the IL-10 family of cytokines (24).”
BackgroundDeubiquitinase DUBA is a post-translational brake on interleukin-17 production in T cells
Rutz, S., Kayagaki, N., Phung, Q. T., Eidenschenk, C., Noubade, R., Wang, X., Lesch, J., Lu, R. O., Newton, K., Huang, O. W., et al. (2014) · Nature · doi:10.1038/nature13979 · Cited by 136
Machado, L. R., & Ottolini, B. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00115 · Cited by 135
“, IL-17 and IL-22) induce expression of defensins from relevant cell types including primary keratinocytes potentially resulting in an amplification of TH17 responses (70).”
BackgroundBüettner, M., & Lochner, M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00342 · Cited by 149
“, by inducing the expression of antimicrobial proteins, such as RegIIIβ and RegIIIγ, by intestinal epithelial cells (81).”
BackgroundHughes, T., Becknell, B., McClory, S., Briercheck, E., Freud, A. G., Zhang, X., Mao, H., Nuovo, G., Yu, J., & Caligiuri, M. A. (2009) · Blood · doi:10.1182/blood-2008-12-192443 · Cited by 121
“IL-22 is a TH17 cytokine that engages a receptor expressed by epithelial tissues resulting in production of antimicrobial peptides which promote the local innate immune response (4, 5).”
BackgroundMa, H., Napierata, L., Stedman, N., Benoit, S., Collins, M. A., Nickerson‐Nutter, C. L., & Young, D. A. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27203 · Cited by 130
Self-citationPlank, M. W., Kaiko, G. E., Maltby, S., Weaver, J., Tay, H. L., Shen, W., Wilson, M. S., Durum, S. K., & Foster, P. S. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601480 · Cited by 126
Bacterial-Host Interactions: Physiology and Pathophysiology of Respiratory Infection
Håkansson, A., Orihuela, C. J., & Bogaert, D. (2018) · Physiological Reviews · doi:10.1152/physrev.00040.2016 · Cited by 142
Interrogating host immunity to predict treatment response in inflammatory bowel disease
Digby-Bell, J. L., Atreya, R. N., Monteleone, G., & Powell, N. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0228-5 · Cited by 135
Cytokine‐regulated Th17 plasticity in human health and diseases
Cerboni, S., Gehrmann, U., Preite, S., & Mitra, S. (2020) · Immunology · doi:10.1111/imm.13280 · Cited by 139
Transition metal ions at the crossroads of mucosal immunity and microbial pathogenesis
Diaz-Ochoa, V. E., Jellbauer, S., Klaus, S., & Raffatellu, M. (2014) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2014.00002 · Cited by 129
“It is also known that lung and intestinal Frontiers in Cellular and Infection Microbiology www.frontiersin.org January 2014 | Volume 4 | Article 2 | 3 epithelial cells express and secrete lipocalin-2 in response to signaling by pro-inflammatory cytokines released by T helper 17 (Th17) cells, like interleukin IL-17 and…”
BackgroundInfluentialChapter 5 Emergence of the Th17 Pathway and Its Role in Host Defense
O’Quinn, D. B., Palmer, M. T., Lee, Y. K., & Weaver, C. T. (2008) · Advances in immunology · doi:10.1016/s0065-2776(08)00605-6 · Cited by 141
Redundant and Pathogenic Roles for IL-22 in Mycobacterial, Protozoan, and Helminth Infections
Wilson, M. S., Feng, C. G., Barber, D. L., Yarovinsky, F., Cheever, A. W., Sher, A., Grigg, M. E., Collins, M. A., Fouser, L. A., & Wynn, T. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903416 · Cited by 142
Self-citationKim, C. J., McKinnon, L. R., Kovacs, C. M., Kandel, G. P., Huibner, S., Chege, D., Shahabi, K., Benko, E., Loutfy, M. R., Ostrowski, M., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300829 · Cited by 128
“IL-17a–producing Th17 cells are an important subset of CD4 T cells that maintains the gut mucosa by inducing the proliferation of epithelial cells (5), promoting antibacterial defensin production (6), and recruiting neutrophils in the context of bacterial invasion (7, 8).”
BackgroundMansouri, Y., & Guttman-Yassky, E. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4050858 · Cited by 124
“IL-22, IL-17, or both may cause the activation of these S100 genes, as these cytokines have been shown to upregulate S100 production in vitro [68,69].”
BackgroundHidden talents of natural killers: NK cells in innate and adaptive immunity
Cooper, M. A., Colonna, M., & Yokoyama, W. M. (2009) · EMBO Reports · doi:10.1038/embor.2009.203 · Cited by 131
“Although IL-22 and IL-26 are part of the cytokine profile of T H 17 CD4 + T cells”
BackgroundCellular sources of IL ‐17 in psoriasis: a paradigm shift?
Keijsers, R. R. M. C., Joosten, I., van Erp, P. E. J., Koenen, H. J. P. M., & van de Kerkhof, P. C. M. (2014) · Experimental Dermatology · doi:10.1111/exd.12487 · Cited by 140
Wozniak, T. M., Saunders, B. M., Ryan, A. A., & Britton, W. J. (2010) · Infection and Immunity · doi:10.1128/iai.01392-09 · Cited by 129
“The IL-17-producing T cells themselves produce other proinflammatory cytokines, including IL-17F, IL-22 (13), and tumor necrosis factor (TNF) (26), and IL-17 stimulates TNF and IL-1 production from macrophages (10), The resulting TNF can partially activate mycobacterium-infected macrophages, even in the absence of IFN…”
Metadata
- Authors
- Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A.
- Affiliations
- 1Inflammation
- 2Antibody Technologies Group, Wyeth Research, Cambridge, MA 02140
- Wyeth (US)
- ORCID
- Collins, Mary
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2006-09-18
- Volume
- 203
- Issue
- 10
- Pages
- 2271-2279
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2118116
- OpenAlex
- W2139008734
- Cited by
- 2,330
- References
- 19
- Citations by year
- 2026: 57 · 2025: 61 · 2024: 80 · 2023: 74 · 2022: 93 · 2021: 118 · 2020: 127 · 2019: 104 · 2018: 104 · 2017: 112 · 2016: 126 · 2015: 132 · 2014: 145 · 2013: 147 · 2012: 156
- FWCI
- 47.05
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Keywords
- IL-22, IL-17A, IL-17F, Th17 cells, antimicrobial peptides, human beta-defensin 2, S100A7, S100A8, S100A9, keratinocytes, skin innate immunity, IL-23, interleukin-6, TGF-beta signaling, cytokine synergy
- MeSH terms
- Interleukin-22, Animals, Cell Differentiation, Immunity, Innate, Interleukins, Mice, Transgenic, Signal Transduction, CD4-Positive T-Lymphocytes, Keratinocytes, Polymerase Chain Reaction, Transforming Growth Factor beta, Interleukin-17, Antimicrobial Cationic Peptides, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.